Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

By sjmartinez • September 27, 2024

Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Tuchayi AM, Lawhn-Heath C, Wang T, Carducci MA, Pomper MG, Paller CJ, Czernin J, Solnes LB, Hope TA, Sartor O, Calais J, Gafita A. Efficacy and Toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data. J Nucl Med. 2024 Sep 26:jnumed.124.267816. doi: 10.2967/jnumed.124.267816. Epub ahead of print. PMID: 39327018.

Tags: Cardiology/Epi, EAP, General Internal Medicine, mCRPC, PSMA PET, Publications, vision

Barriers and Emerging Strategies to Bridge Gaps in Implementation of Evidence-Based Lipid-Lowering Therapies

Marnell CS, Koenig W, Bittner V, Watson KE, Muntner P, Nordestgaard BG, Yan LL, Verbakel M, Rosenson RS. Barriers and Emerging Strategies to Bridge Gaps[...]

New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American Indian Women Service Members

Jeon-Slaughter H, Whyne EZ, Doyle C, Chen X, Chiou SH, Tsai S, Ebrahimi R. New 10-Year Atherosclerosis Cardiovascular Disease Risk Score for Asian and American[...]

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]